-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622A.O3.6 622. Non-Hodgkin Lymphoma: Biology, excluding Therapy: New Targets In Aggressive Lymphoma

Non-Hodgkin Lymphoma: Biology, excluding Therapy Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 2:45 PM-4:15 PM
W311EFGH, Level 3 (Orange County Convention Center)
Moderators:
Jennifer Effie Amengual, MD, Columbia University Medical Center and Andrew L Feldman, MD, Mayo Clinic

Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Delphine CM Rolland, Pharm D, PhD1*, Venkatesha Basrur, PhD2*, Yoon Kyung Jeon, MD, PhD3*, Carla McNeil-Schwalm, MD4*, Damian Fermin, PhD2*, Kevin Conlon, MS2*, Chih-Chiang Tsou, PhD2*, Noah A Brown, MD2*, Dafydd G Thomas, MD, PhD2*, Nathanael G. Bailey, MD2, Gilbert S Omenn, MD, PhD5*, Alexey I Nesvizhskii, PhD2*, Megan S Lim, MD, PhD1* and Kojo SJ Elenitoba-Johnson, MD1*

1Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
2Department of Pathology, University of Michigan, Ann Arbor, MI
3Department of Pathology, Seoul National University Hospital, Seoul, South Korea
4Department of Pediatric Hematology and Oncology, Iowa Methodist Medical Center, Des Moines, IA
5Department of Internal Medicine, University of Michigan, Ann Arbor, MI

3:00 PM

Jie Xiong, Ph.D1,2*, Li Wang, M.D/Ph.D1,2* and Weili Zhao, M.D/Ph.D1,2

1State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Pôle de Recherches Sino-Français en Science du Vivant et Génomique, Laboratory of Molecular Pathology, Shanghai, China

3:15 PM

Hsu-Ping Kuo, Sidney Hsieh*, Karl J. Schweighofer*, Leo WK Cheung*, Shiquan Wu*, Mutiah Apatira*, Mint Sirisawad*, Karl Eckert*, Yu Liang*, Jeff Hsu* and Betty Y. Chang, PhD

Research Department, Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA

3:30 PM

Olli Dufva, BMed1*, Tiina Kelkka, PhD1*, Shady Awad, MD1*, Nodoka Sekiguchi, MD2*, Heikki Kuusanmäki, MSc1,3*, Emma I Andersson, MSc1*, Samuli Eldfors, MSc3*, Disha Malani, MSc3*, Paavo Pietarinen, MSc1*, Leena Saikko4*, Panu E Kovanen, MD, PhD4*, Junji Suzumiya, MD, PhD5, Koichi Ohshima, MD, PhD6*, Young Hyeh Ko, MD7*, Won Seog Kim, MD, PhD8*, Shih-Sung Chuang, MD9*, Thomas P. Loughran Jr., MD10, Wing C Chan, MD11*, Fumihiro Ishida, MD, PhD2 and Satu Mustjoki, MD, PhD1

1Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
2Second Dept. of Int. Med., Shinshu University, Matsumoto, Japan
3Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
4Department of Pathology, HUSLAB and Haartman Institute, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
5Department of Oncology/Hematology, Shimane University Hospital Cancer Center, Izumo, Japan
6Department of Pathology, Kurume University, School of Medicine, Kurume, Japan
7Department of Pathology, Samsung Medical Center, Seoul, South Korea
8Samsung Medical Center, Seoul, South Korea
9Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan
10University of Virginia Cancer Center, Charlottesville, VA
11Department of Pathology, City of Hope Medical Center, Duarte, CA

3:45 PM

Riccardo Bomben1*, Simone Ferrero2*, Michele Dal Bo1*, Tiziana D'Agaro1*, Alessandro Re3*, Andrea Evangelista4*, Angelo Michele Carella5, Alberto Zamò6*, Umberto Vitolo, MD7, Paola Omedè2*, Chiara Rusconi8*, Luca Arcaini9*, Luigi Rigacci10, Stefano Luminari, MD11*, Sergio Cortelazzo12, Marco Ladetto13 and Valter Gattei, MD1

1Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy
2Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Torino, Italy
3Hematology, Spedali Civili, Brescia, Italy
4Unit of Cancer Epidemiology, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Torino, Italy
5Division of Hematology 1, IRCCS A.O.U. San Martino IST, Genova, Genova, Italy
6Department of Pathology, University of Verona, Verona, Italy
7Città della Salute e della Scienza Hospital and University, SC Hematology, Turin, Italy
8Division of Hematology, Niguarda Ca' Granda Hospital, Milano, Italy
9Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
10Hematology, Universita' degli Studi di Firenze, Florence, Italy
11Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
12Department of Haematology and Bone Marrow Transplantation, Regional Hospital, S. Maurizio, Bolzano/Bozen, Italy
13Division of Hematology, Az Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

4:00 PM

Xiaoyu Jiang, PhD1*, Xiaoqing Lu2*, Brett J Schuchardt3*, David C Mikles3*, Amjad Farooq3*, Vincent Moy, PhD4* and Izidore S Lossos, MD1

1Division of Oncology-Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL
2University of Miami Miller School of Medicine, Miami, FL
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL
4Department of Physiology & Biophysics, University of Miami Miller School of Medicine, Miami, FL

*signifies non-member of ASH